Wegovy-maker Novo Nordisk shares surge after GLP-1 pill approval
Shares in Novo Nordisk surged 6.9% Tuesday, after the Wegovy maker secured approval of its GLP-1 pill — a world first. The U.S. Food and Drug Administration’s approval of Novo Nordisk’s GLP-1 pill gives the Danish pharmaceutical giant a head start over U.S. rival Eli Lilly. The pill’s starting dose of 1.5 milligrams will be…